WARSAW, Ind., Sept. 14, 2021 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today announced key appointments to the "NewCo" leadership
team, including Richard J.
Heppenstall as Executive Vice President and Chief Financial
Officer. Additionally, the Company announced ZimVie as the name for
the planned spin-off company for the Spine and Dental businesses.
Zimmer Biomet announced in February
2021 its intent to form a new independent, publicly traded
company to optimize resource allocation and drive toward market
leadership. That transaction process remains on track, with an
expected close in mid-2022.
Mr. Heppenstall brings more than 25 years of broad corporate and
operational finance experience to ZimVie, most recently serving as
Chief Financial Officer of Breg, Inc., a global manufacturer and
solutions provider of orthopedic braces, cold therapy and other
medical equipment.
"Rich is joining ZimVie at an instrumental time for the company,
as we continue to shape our operating model and business plans in
preparation for the planned spin-off," said Vafa Jamali, CEO of ZimVie. "His extensive
experience across all areas of finance within the medtech space
will be critically important as we advance toward the formation of
a new independent company for our Spine and Dental businesses."
Mr. Heppenstall previously held senior leadership roles at
Orthofix International, Solera Holdings, Flowserve Corporation and
Coopervision Inc., among others. He holds a master's degree in
Business Administration from Santa Clara
University and a Bachelor of Arts in Economics from
University of California, Irvine.
In addition to Mr. Heppenstall, the following team members have
been appointed to the ZimVie leadership team, reporting directly to
Mr. Jamali.
- Vincent Binetti, General
Manager, Bone Healing
- Laura Driscoll, Vice President,
Communications
- David Harmon, Senior Vice
President, Chief Human Resources Officer
- Indraneel Kanaglekar, Senior Vice President, President, Global
Dental
- Heather Kidwell, Senior Vice
President, Chief Legal and Compliance Officer
- Mike Minette, Senior Vice
President, Strategy and Corporate Development
- Ann Vu, Senior Vice President,
Regulatory Affairs and Quality Assurance
- Rebecca Whitney, Senior Vice
President, President, Global Spine
"I'm incredibly excited to bring on such a seasoned leadership
team to drive ZimVie forward following the separation. With their
collective experience, I know we have the right leaders in place to
set ZimVie up for success," continued Mr. Jamali.
About the Company
Zimmer Biomet is a global medical technology leader
with a comprehensive portfolio designed to maximize mobility and
improve health. We seamlessly transform the patient experience
through our innovative products and suite of integrated digital and
robotic technologies that leverage data, data analytics and
artificial intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to
come to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet on
Twitter at www.twitter.com/zimmerbiomet.
Cautionary Note Regarding Forward-Looking
Statements
This news release contains forward-looking
statements within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to,
statements concerning our expectations, plans, intentions,
strategies or prospects, the anticipated spin-off of our Spine and
Dental businesses and the expected timetable for completing the
transaction. All statements other than statements of
historical or current fact are, or may be deemed to be,
forward-looking statements. Such statements are based upon
the current beliefs, expectations and assumptions of management and
are subject to significant risks, uncertainties and changes in
circumstances that could cause actual outcomes and results to
differ materially from the forward-looking statements, including
but not limited to risks and uncertainties regarding economic,
competitive, governmental, regulatory and technological factors
affecting our operations, markets, products, services, customers
and suppliers, the impact of the COVID-19 pandemic, as well as any
changes in or abandonment of the proposed transaction and our
ability to satisfy the conditions to the proposed transaction, and
such forward-looking statements are not guarantees of future
performance. A further list and description of these risks
and uncertainties and other factors can be found in our Annual
Report on Form 10-K for the year ended December 31, 2020, including in the sections
captioned "Cautionary Note Regarding Forward-Looking Statements"
and "Item 1A. Risk Factors," and our subsequent filings with the
Securities and Exchange Commission (SEC). Copies of these
filings are available online at www.sec.gov,
www.zimmerbiomet.com or on request from us.
These factors should not be construed as exhaustive and should be
read in conjunction with the other cautionary statements that are
included in our filings with the SEC. Forward-looking
statements speak only as of the date they are made, and we
expressly disclaim any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise. Readers of this news
release are cautioned not to rely on these forward-looking
statements since there can be no assurance that these
forward-looking statements will prove to be accurate. This
cautionary note is applicable to all forward-looking statements
contained in this news release.
Media
|
|
Investors
|
Meredith
Weissman
|
|
Keri Mattox
|
703-346-3127
|
|
215-275-2431
|
meredith.weissman@zimmerbiomet.com
|
|
keri.mattox@zimmerbiomet.com
|
|
|
Ezgi Yagci 617-549-2443 ezgi.yagci@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-key-additions-to-newco-leadership-team-transaction-to-form-new-independent-publicly-traded-company-on-track-301375803.html
SOURCE Zimmer Biomet Holdings, Inc.